According to The Insight Partners market research study of ‘North America Nasal Delivery Devices Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by drug type, delivery technologies, and end user’ the North America nasal delivery devices market is expected to reach US$ 36,940.74 million in 2027 from US$ 21,932.47 in 2019. The market is estimated to grow with a CAGR of 6.8% from 2020-2027. The report provides trends prevailing in the North America nasal delivery devices market and the factors driving market along with those that act as hindrances.
Request For Sample Reports @ https://www.theinsightpartners.com/sample/TIPRE00018194/
- GlaxoSmithKline plc.
- Pfizer Inc.
- Merck & Co., Inc.
- Cadila Pharmaceuticals Ltd.
- Novartis AG
- Dr. Reddy’s Laboratories
- Neurelis, Inc.
Based on the drug type, the North America the nasal delivery devices market, is segmented into anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. The antihistamines segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. Antihistamines are drugs/ medication which is used in treatment of allergic rhinitis and other allergies. Several times people take antihistamines as an inexpensive, generic, over-the-counter drug that can provide relief from sneezing, nasal congestion, or hives caused by pollen, dust mites, or animal allergy with few side effects. The four intranasal histamine-1 receptor antagonist (H1-antihistamines) products that are approved for the management of rhinitis include azelastine (Astelin, Astepro), olopatadine (Patanase) and azelastine hydrochloride/fluticasone propionate (Dymista).
The growth of the market is attributed to some key driving factors such as the rising prevalence of respiratory diseases and the superior outcomes of intranasal drug delivery among patients. However, the market growth is likely to be hindered owing to the limitations regarding drug delivery medications.
GlaxoSmithKline plc., AstraZeneca, Pfizer Inc., BD are among the leading companies operating in the North America nasal delivery devices market.
NORTH AMERICA NASAL DELIVERY DEVICES MARKET SEGMENTATION
By Drug Type
- Pain Relief Drugs
- Calcium Supplements
By Delivery Technologies
By End User
- Home Care Settings
- North America
You Can Buy This Report from Here@ https://www.theinsightpartners.com/buy/TIPRE00018194/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.